Vamsi K.
Vamsi K. Chemitiganti, Coatesville, PA US
Patent application number | Description | Published |
---|---|---|
20100049756 | Medical Intelligence Framework - A framework executing on a computational structure and supporting a plurality of simultaneously executing software applications with a shared layer, wherein the framework is disposed between the plurality of applications and a set of data sources, the framework decomposing, processing, and analyzing data passed between the plurality of applications and the data sources into information elements. | 02-25-2010 |
Vamsi K. Doddakula, Dunlap, IL US
Patent application number | Description | Published |
---|---|---|
20130105263 | END HORNS FOR PANTOGRAPH ASSEMBLY | 05-02-2013 |
20130105264 | PANTOGRAPH ASSEMBLY | 05-02-2013 |
Vamsi K. Dokku, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090323686 | METHODS AND APPARATUSES TO REDUCE CONTEXT SWITCHING DURING DATA TRANSMISSION AND RECEPTION IN A MULTI-PROCESSOR DEVICE - A method and apparatus are provided for efficiently transferring data between a first and second processors having shared memory. A plurality of data packets are aggregated into a packet bundle at the first processor. The packet bundle is then transferred from the first processor to the second processor using the shared memory, wherein the transfer of the packet bundle is performed in a single context switch at the first processor. The packet bundle is then unbundled into individual data packets at the second processor, wherein a processing load of the second processor is reduced due to the aggregation of the data packets into the packet bundle by the first processor. | 12-31-2009 |
20140171087 | APPARATUS AND METHODS FOR ENHANCED USER EQUIPMENT POWER MANAGEMENT VIA CONTROLLED CELL CHANGE NOTIFICATIONS - Apparatus and methods for power management in a wireless communication device include detecting a change in a serving cell for data communication from a first cell to a second cell; determining whether a terminal equipment (TE) is in a low power state; detecting a first technology type of the first cell and a second technology type of the second cell; determining whether the second technology type is a different technology mode than the first technology type; sending a cell change notification to a data processor associated with the TE when the second technology type is in the different technology mode than the first technology type and the TE is not in a low power state; and suppressing the sending of the cell change notification when the second technology type is not in the different technology mode and the TE is in the low power state. | 06-19-2014 |
Vamsi K. Ithapu, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20160073969 | Medical Imaging System Providing Disease Prognosis - A medical imaging system that processes input data (imaging and/or non imaging) having high dimensionality and few samples to learn from, by using multiple ranks of machine learning modules each dealing with a separate portion of the clinical data. The outputs of the individual machine learning modules are the combined to provide a result reflective of the complete image data set. | 03-17-2016 |
Vamsi K. Jarugumilli, Charlotte, NC US
Patent application number | Description | Published |
---|---|---|
20090276257 | System and Method for Determining and Managing Risk Associated with a Business Relationship Between an Organization and a Third Party Supplier - Aspects of this invention are directed to a method for determining and managing risk associated with a business relationship between an organization and a third party supplier. A further aspect of this invention relates to a system that allows the organization to manage risk and compliance processes. Further aspects of this invention relate to identifying a potential third party for conducting a business relationship, obtaining information about the third party relating to the risk associated with the business relationship with the third party, and generating at least one score related to the risk associated with the business relationship with the third party. | 11-05-2009 |
Vamsi K. Mootha, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20120136007 | METHODS AND COMPOSITIONS FOR TREATING DEGENERATIVE AND ISCHEMIC DISORDERS - Model systems have shown that shifting a cell's reliance from oxidative phosphorylation (OXPHOS) to glycolysis can protect against cell death. Exploiting the therapeutic potential of this strategy, however, has been limited by the lack of clinically safe agents that remodel energy metabolism. The present invention identifies non-toxic small molecules (e.g., drug-like compounds) that are capable of modulating oxidative metabolism. One identified compound comprises meclizine. As described herein, meclizine, and its enantiomer S-meclizine, redirects OXPHOS to glycolysis. Such compounds could be protective or therapeutic in degenerative disorders such as diabetes, Huntington's, Parkinson's, and Alzheimer's disease and/or ischemic disorders including, but not limited to, stroke, heart attack, or reperfusion injuries. | 05-31-2012 |
20160032401 | Glycine, Mitochondrial One-Carbon Metabolism, and Cancer - Methods of treatment, diagnosis, and determining prognosis of subjects with cancer, generally comprising determining levels of glycine metabolism or a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2, MTHFD1L, or MTHFD2, and optionally administering an antifolate or an agent that inhibits a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2 or MTHFD2. | 02-04-2016 |
Vamsi K. Mootha, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20090068170 | DROPLET-BASED SELECTION - The present invention generally relates to fluidic droplets, and techniques for screening or sorting such fluidic droplets. In some embodiments, the fluidic droplets may contain cells (e.g., hybridoma cells) that can secrete various species, such as antibodies, for example. In one aspect, a plurality of fluidic droplets containing cells is screened to determine proteins, antibodies, polypeptides, peptides, nucleic acids, or the like. For example, cells able to secrete species such as antibodies may be selected according to certain embodiments of the invention. Examples of such cells include, for instance, immortal cells such as hybridomas, or non-immortal cells such as B-cells. For instance, blood cells may be encapsulated within a plurality of fluidic droplets, and the cells able to produce antibodies may be determined. In some cases, expression or secretion levels may be determined using signaling entities, for example, determinable microparticles present within the fluidic droplet. Other aspects of the invention relate to kits involving such fluidic droplets, methods of promoting the making or use of such fluidic droplets, and the like. | 03-12-2009 |
20110311650 | MULTIPLEXED BIOMARKERS OF INSULIN RESISTANCE - The invention, in some aspects, relates to methods for characterizing glucose-related metabolic disorders. In some aspects, the invention relates to methods and kits useful for diagnosing, classifying, profiling, and treating glucose-related metabolic disorders. In some aspects, the invention relates to methods useful for diagnosing, classifying, profiling, and treating diabetes. | 12-22-2011 |
20120015382 | DROPLET-BASED SELECTION - The present invention generally relates to fluidic droplets, and techniques for screening or sorting such fluidic droplets. In some embodiments, the fluidic droplets may contain cells (e.g., hybridoma cells) that can secrete various species, such as antibodies, for example. In one aspect, a plurality of fluidic droplets containing cells is screened to determine proteins, antibodies, polypeptides, peptides, nucleic acids, or the like. For example, cells able to secrete species such as antibodies may be selected according to certain embodiments of the invention. Examples of such cells include, for instance, immortal cells such as hybridomas, or non-immortal cells such as B-cells. For instance, blood cells may be encapsulated within a plurality of fluidic droplets, and the cells able to produce antibodies may be determined. In some cases, expression or secretion levels may be determined using signaling entities, for example, determinable microparticles present within the fluidic droplet. Other aspects of the invention relate to kits involving such fluidic droplets, methods of promoting the making or use of such fluidic droplets, and the like. | 01-19-2012 |
Vamsi K. Mudhivarthi, Storrs, CT US
Patent application number | Description | Published |
---|---|---|
20130196406 | NOVEL PROTEIN-POLYMER NANOCAPSULES - Disclosed are protein nanocapsules, and in particular, nanocapsules that have high thermal stability and very high resistance to thermal inactivation when subjected to steam sterilization. | 08-01-2013 |
Vamsi K. Potluru, Albuquerque, NM US
Patent application number | Description | Published |
---|---|---|
20150281838 | Method and System for Detecting Events in an Acoustic Signal Subject to Cyclo-Stationary Noise - A method detects events in an accoustic signal subject to cyclostationary background noise by first segmenting the signal into cycles. Features with a fixed dimension are derived from the cycles, such that the timing of the features is relative to a cycle time. The features are normalized using an estimate of the cyclostationary background noise. Then, after the normalizing, a classifier is applied to the features to detect the events. | 10-01-2015 |